View Clinical Trial (Medical Research Study)

Dronabinol Treatment for Marijuana Addiction - NCT00217971-10032(Clinical Trial 130788)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  New York
State:  
NY
Zip Code: 10032
Conditions: Marijuana Abuse
Purpose: The purpose of this study is to determine if dronabinol decreases the symptoms of marijuana addiction and withdrawal.
Study summary: Marijuana addiction is associated with significant withdrawal symptoms, including anxiety, irritability, bodily discomfort, and insomnia. The purpose of this study is to determine the effectiveness of dronabinol in reducing withdrawal symptoms. During this twelve-week, double-blind, placebo-controlled study, study visits will occur twice each week. During study visits, participants will receive either placebo or medication. Throughout the study, all participants will receive individualized psychotherapy sessions. At each study visit, vital signs, self-report ratings, and urine samples will be collected. Participants will have a follow-up evaluation at month 6.
Criteria: Inclusion Criteria: - Meets DSM-IV criteria for current marijuana dependence and reports marijuana as primary drug of abuse - Individuals must report using marijuana at least 5 days a week and have a marijuana positive urine drug screen on the day of study entry Exclusion Criteria: - Meets criteria for current psychiatric disorder requiring psychiatric intervention - History of seizures - Known sensitivity to dronabinol - Unstable medical conditions - Physical dependence on any other drugs (excluding nicotine) that would require medical detoxification - Currently taking psychotropic medication with benefit for any other illness than treatment of insomnia - Pregnant or breast-feeding
Study is available at: Research Foundation for Mental Hygiene, Inc.
New York, NY 10032
United States

Primary Contact:
Substance Abuse Treatment and Research Service
Phone: 212-923-3031
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 21, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.